Drug-eluting stents in acute myocardial infarction: updated meta-analysis of randomized trials

[1]  B. Gersh,et al.  Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. , 2009, The New England journal of medicine.

[2]  R. Blindt,et al.  The risk of definitive stent thrombosis is increased after “off-label” stent implantation irrespective of drug-eluting stent or bare-metal stent use , 2009, Clinical Research in Cardiology.

[3]  G. Stone,et al.  Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. , 2009, International journal of cardiology.

[4]  Oliver Koeth,et al.  Efficacy of a 24-h primary percutaneous coronary intervention service on outcome in patients with ST elevation myocardial infarction in clinical practice , 2009, Clinical Research in Cardiology.

[5]  A. Gitt,et al.  Angioplasty within 24 h after thrombolysis in patients with acute ST-elevation myocardial infarction: current use, predictors and outcome , 2009, Clinical Research in Cardiology.

[6]  S. Normand,et al.  Drug-eluting or bare-metal stents for acute myocardial infarction. , 2008, The New England journal of medicine.

[7]  C. Terkelsen,et al.  Drug-Eluting Versus Bare Metal Stents in Patients With ST-Segment–Elevation Myocardial Infarction: Eight-Month Follow-Up in the Drug Elution and Distal Protection in Acute Myocardial Infarction (DEDICATION) Trial , 2008, Circulation.

[8]  M. Pfisterer,et al.  Late stent thrombosis after drug-eluting stent implantation for acute myocardial infarction: a new red flag is raised. , 2008, Circulation.

[9]  Aloke V. Finn,et al.  Delayed Arterial Healing and Increased Late Stent Thrombosis at Culprit Sites After Drug-Eluting Stent Placement for Acute Myocardial Infarction Patients: An Autopsy Study , 2008, Circulation.

[10]  P. Serruys,et al.  Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction: Long-Term Outcome After Bare Metal and Drug-Eluting Stent Implantation , 2008, Circulation. Cardiovascular interventions.

[11]  M. Pfisterer,et al.  Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis , 2008, BMJ : British Medical Journal.

[12]  M. Niemelä,et al.  Titanium-nitride-oxide coated stents versus paclitaxel-eluting stents in acute myocardial infarction: a 12-months follow-up report from the TITAX AMI trial. , 2008, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[13]  G. Stone,et al.  Coronary stenting versus balloon angioplasty for acute myocardial infarction: a meta-regression analysis of randomized trials. , 2008, International journal of cardiology.

[14]  F. Prati,et al.  Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial. , 2008, JAMA.

[15]  H. Putter,et al.  Sirolimus-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome results from the MISSION! Intervention Study. , 2008, Journal of the American College of Cardiology.

[16]  Marco Valgimigli,et al.  Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction. , 2007, European heart journal.

[17]  Michail I. Papafaklis,et al.  Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden. , 2007, Journal of the American College of Cardiology.

[18]  G. Biondi Zoccai,et al.  Single-center randomized evaluation of paclitaxel-eluting versus conventional stent in acute myocardial infarction (SELECTION). , 2007, Journal of interventional cardiology.

[19]  Ángel Martínez,et al.  Sirolimus-eluting stents compared with standard stents in the treatment of patients with primary angioplasty. , 2007, American heart journal.

[20]  Arianna Azzellino,et al.  Randomized trial of Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (SESAMI). , 2007, Journal of the American College of Cardiology.

[21]  P. Serruys,et al.  Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions , 2007, Circulation.

[22]  V. Pasceri,et al.  Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction. , 2007, American heart journal.

[23]  Marco Valgimigli,et al.  Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. , 2007, The New England journal of medicine.

[24]  Michael Joner,et al.  Drug-Eluting Stent and Coronary Thrombosis: Biological Mechanisms and Clinical Implications , 2007, Circulation.

[25]  Neville Kukreja,et al.  Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study , 2007, The Lancet.

[26]  A. Kastrati,et al.  Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis: meta-analysis of randomized trials. , 2007, Journal of the American College of Cardiology.

[27]  J. Tijssen,et al.  Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. , 2006, The New England journal of medicine.

[28]  E. Bramucci,et al.  Sirolimus-eluting versus uncoated stents in acute myocardial infarction. , 2006, The New England journal of medicine.

[29]  Seung‐Jung Park,et al.  Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up. , 2006, The American journal of cardiology.

[30]  Barbara T. Unger,et al.  Comparison of safety and efficacy of sirolimus-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction. , 2006, The American journal of cardiology.

[31]  G. Campo,et al.  Safety and Long-Term Efficacy of Sirolimus Eluting Stent in ST-elevation Acute Myocardial Infarction: The REAL (Registro REgionale AngiopLastiche Emilia-Romagna) Registry , 2006, Cardiovascular Drugs and Therapy.

[32]  R. Ferrari,et al.  Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial. , 2005, JAMA.

[33]  T. Harr,et al.  Primary stenting versus primary balloon angioplasty for treating acute myocardial infarction. , 2005, The Cochrane database of systematic reviews.

[34]  J. Ottervanger,et al.  Is routine stenting for acute myocardial infarction superior to balloon angioplasty? A randomised comparison in a large cohort of unselected patients , 2005, Heart.

[35]  P. Serruys,et al.  Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction. , 2004, Journal of the American College of Cardiology.

[36]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[37]  Jeroen J. Bax,et al.  Preoperative comparison of different noninvasive strategies for predicting improvement in left ventricular function after coronary artery bypass grafting. , 2003, The American journal of cardiology.

[38]  J. J. Griffin,et al.  Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. , 2002, The New England journal of medicine.

[39]  D. Altman,et al.  Concealing treatment allocation in randomised trials , 2001, BMJ : British Medical Journal.

[40]  L. Clark,et al.  Primary stent implantation compared with primary balloon angioplasty for acute myocardial infarction: a meta-analysis of randomized clinical trials. , 2001, The American journal of cardiology.

[41]  Douglas G Altman,et al.  Systematic reviews of evaluations of prognostic variables , 2001, BMJ : British Medical Journal.

[42]  D. Altman,et al.  Systematic reviews in health care: Assessing the quality of controlled clinical trials. , 2001, BMJ.

[43]  P. Serruys,et al.  A comparison of systematic stenting and conventional balloon angioplasty during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. STENTIM-2 Investigators. , 2000, Journal of the American College of Cardiology.

[44]  Bruce R. Brodie,et al.  Coronary Angioplasty with or without Stent Implantation for Acute Myocardial Infarction , 1999 .

[45]  P. Kligfield.  Primary angioplasty in myocardial infarction. , 1995, British heart journal.

[46]  C. Begg,et al.  Operating characteristics of a rank correlation test for publication bias. , 1994, Biometrics.

[47]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[48]  A. Kastrati,et al.  Prognostic value of minimal blood flow restoration in patients with acute myocardial infarction after reperfusion therapy , 2009, Clinical Research in Cardiology.

[49]  G. Richardt,et al.  Multi-vessel stenting during primary percutaneous coronary intervention for acute myocardial infarction , 2007, Clinical Research in Cardiology.